Laboratory Evaluation of Intestinal Infections - PowerPoint PPT Presentation

1 / 50
About This Presentation
Title:

Laboratory Evaluation of Intestinal Infections

Description:

... of colitis with crypt abscesses and erosive ulceration of colonic mucosa ... Bacteremic dissemination with hepatic and splenic abscess formation ... – PowerPoint PPT presentation

Number of Views:138
Avg rating:3.0/5.0
Slides: 51
Provided by: johnrw6
Category:

less

Transcript and Presenter's Notes

Title: Laboratory Evaluation of Intestinal Infections


1
Laboratory Evaluation of Intestinal Infections
  • Dr. John R. Warren
  • Department of Pathology
  • Northwestern University
  • Feinberg School of Medicine
  • June 2007

2
Intestinal Infections
  • Pathophysiology, clinical features, and
    microbiology
  • Laboratory detection of enteric pathogens
  • Guidelines for laboratory evaluation of
    intestinal infections

3
Pathophysiology, Clinical Features, and
Microbiology
  • Acute dysentery
  • Enteric fever
  • Mesenteric adenitis
  • Antibiotic-associated colitis

4
Acute dysentery
  • Frequent bowel movements accompanied by visible
    blood, mucus, fecal leukocytes, and tenesmus
  • Pathologic changes of intestinal mucosa include
    moderate to intense exudative (neutrophilic)
    inflammation, often hemorrhage, and formation of
    superficial ulcers

5
Acute dysentery
  • Shigella
  • Salmonella
  • Campylobacter jejuni
  • Enterohemorrhagic Escherichia coli
  • Yersinia enterocolitica

6
Shigella
  • Fermentative, non-motile, small gram-negative
    bacilli
  • Facultative intracellular parasite (colonic
    epithelial cell)
  • Four species S. dysenteriae (serogroup A), S.
    flexneri (serogroup B), S. boydii (serogroup C),
    and S. sonnei (serogroup D)
  • Elaborates potent exotoxin (Shiga toxin) with
    enterotoxic, cytotoxic, and neurotoxic properties
  • Invades colonic epithelial cells provoking
    neutrophilic inflammatory response
  • Infection produces widespread, shallow colonic
    mucosal ulcers 3-7 mm in diameter with intense
    inflammatory exudate

7
Shigellosis
  • Incubation period from 6 hours to 9 days, usually
    less than 3 days, after person to person
    transmission by fecal-oral route
  • Acute bloody dysentery with high fever, abdominal
    pain, malaise, headache, occasionally meningismus
    and fever
  • Most common cause of bloody diarrhea in children
  • Syndrome particularly severe in malnourished
    children

8
Complications of Shigellosis
  • Untreated diarrhea lasts 1 day to 1 month with
    average of 7 days
  • Severe dehydration
  • Febrile seizures
  • Intestinal obstruction (3)
  • Hemolytic-uremic syndrome (Shiga toxin-producing
    S. dysenterieae 1)
  • Post-infectious arthritis (2-5 weeks after acute
    dysentery) associated with the histocompatibility
    antigen HLA-B27 (S. flexneri)
  • Bacteremia and disseminated infection rare

9
Salmonella
  • Fermentative, non-spore forming, motile
    gram-negative bacilli
  • Facultative intracellular parasite (intestinal
    epithelial cells, macrophages)
  • Single species (Salmonella enterica) with 1,454
    serotypes in genetic subspecies 1 (Group I)
    having O-antigen groups A, B, C1, C2, D, E
  • Subspecies 1 strains usually isolated from humans
    and other warm-blooded animals
  • Nomenclature Salmonella serotype Dublin
  • Salmonella serotype Typhimurium and S. serotype
    Enteritidis most frequent cause of salmonellosis

10
Salmonellosis
  • Fever, cramping, abdominal pain, and diarrhea
    within 8-48 hours after ingestion of infective
    dose (contaminated poultry, shell eggs, dairy
    products, beef, exotic pets such as reptiles)
  • Inflammatory (neutrophilic) enteritis most
    typically involving the small bowel mucosa,
    occasional cause of colitis with crypt abscesses
    and erosive ulceration of colonic mucosa
    (Salmonella serotype Typhimurium)
  • Moderate number of fecal neutrophils, usually
    fewer than in shigellosis except colitis with
    blood and pus in stool

11
Complications of Salmonellosis
  • Diarrhea usually self-limited (3-7 days), if
    persists gt10 days another microbial etiology
    likely
  • Occasional dehydration requiring hospitalization
  • Bacteremia (1-4 immunocompetent cases)
    (persistent bacteremia suggests endovascular
    infection site such as atherosclerotic plaques
    and aneurysms)
  • After resolution of diarrhea mean duration of
    carriage in stool is 4-5 weeks

12
Campylobacter jejuni
  • Microaerophilic, thermophilic, motile, S-shaped
    gram-negative bacilli
  • Adhere to and invade intestinal epithelial cells
  • Optimal growth at 42oC in ambient gas mixture of
    5 O2, 10 CO2, and 85 N2

13
Campylobacteriosis
  • Severe abdominal pain with fever and diarrhea 1-7
    days after infectious dose (poultry, raw milk,
    contact with infected pets, fecal-oral route)
  • Campylobacter jejuni multiplies in human bile,
    facilitating initial colonization of small
    intestine
  • Tissue injury with invasion includes jejunum,
    ileum, and colon, provoking a mixed
    neutrophilic-mononuclear cell inflammatory
    response with erosive mucosal ulceration

14
Complications of Campylobacteriosis
  • Enteritis usually self-limiting (1 day to 1 week
    or longer)
  • Guillain-Barré syndrome (structural homology of
    LPS O-antigen with human nerve gangliosides)
  • Post-infectious reactive arthritis (associated
    with HLA-B27)
  • Bacteremia (rate of 1.5/1,000 intestinal
    infections)

15
Enterohemorrhagic Escherichia coli
  • Non-sorbitol fermenting Escherichia coli
    (Escherichia coli 94 for sorbitol
    fermentation)
  • Majority of enterohemorrhagic strains positive
    for somatic O157 and flagellar H7 antigens (O104
    and O111 strains have caused outbreaks in the US)
  • Bacteriophage-mediated production of Shiga-like
    toxin (Stx1 or Stx2) which are cytotoxic
    (verotoxin)
  • Accounts for 15 to 36 of cases of bloody
    diarrhea

16
Enterohemorrhagic Escherichia coli Diarrhea
  • Abdominal cramps and watery diarrhea 3 to 8 days
    following ingestion of contaminated food
    (undercooked beef, raw milk, fresh produce) or
    water
  • Shiga toxin absorbed from intestine and damages
    vascular endothelial cells (intestinal mucosa and
    kidney)
  • Watery diarrhea followed by grossly bloody
    diarrhea
  • Uncomplicated illness lasts 1 to 12 days
  • Use of antibiotics contraindicated
    (phage-mediated production of Shiga toxin
    enhanced by ampicillin, norfloxacin, and other
    antibiotics)

17
Complications of Hemorrhagic Escherichia coli
Colitis
  • Fever and neutrophilic leukocytosis herald
    hemolytic uremic syndrome (HUS)
    (thrombocytopenia, oliguria, hematuria,
    microangiopathic hemolytic anemia)
  • HUS in 8 of infections in children with a 3 to
    5 mortality

18
Yersinia enterocolitica
  • Fermentative, rod-shaped or coccoid gram-negative
    bacteria, non-motile and metabolically inactive
    at 37oC but motile and metabolically active at
    22-30oC
  • Enteropathogenic strains cytotoxic by
    penetratating human epithelial cells
  • Infection results in inflammatory ileitis
    (generally) and colitis (occasionally involving
    ascending colon) with mixed neutrophilic and
    mononuclear cell response
  • Necrosis of Peyers patches, mesenteric lymph
    node enlargement, and in severe cases thrombosis
    of mesenteric blood vessels with intestinal
    necrosis and hemorrhage

19
Yersinosis
  • Febrile diarrhea with abdominal pain 16 to 48
    hours following ingestion of an infectious
    inoculum (undercooked pork, chitterlings1)
  • Duration of illness ranges from 1 day to a
    prolonged diarrhea of 4 weeks
  • 1Chitterlings (chitlins) intestines of young
    pigs, cleaned and stewed, and then frequently
    battered and fried

20
Complications of Yersinosis
  • Can simulate acute appendicitis (mesenteric
    lymphadenitis)
  • Bacteremic dissemination with hepatic and splenic
    abscess formation
  • Reactive arthritis associated with HLA-B27
    histocompatibility antigen (10-30)
  • Exudative pharyngitis (8 of infections
    accompanied by fever but no diarrhea)

21
Infective Dose of Enteric Pathogens
  • Shigella 10 to 102
  • Campylobacter jejuni 102 to 106
  • Salmonella 105
  • Escherichia coli 108
  • Yersinia 109

22
Enteric Infections United States 2002 (CDC)1
  • Salmonella 16.10
  • Campylobacter 13.17
  • Shigella 10.34
  • Escherichia coli O157H7 1.73
  • Yersinia 0.44
  • 1Incidence per 100,000 population

23
Enteric Infections United States 2004 (CDC)1,2
  • Salmonella 14.7
  • Campylobacter 12.9
  • Shigella 5.1
  • Yersinia 3.9
  • Escherichia coli O157H7 0.9
  • 1CDC FoodNet (10 States)
  • 2Incidence per 100,000 population

24
Mortality of Enteric Infections 2001 (Notifiable
Diseases, CDC)
  • Cases Deaths ()
  • Salmonellosis 40,495 40 (0.1)
  • Shigellosis 20,221 2 (0.01)
  • Hemorrhagic E. coli1 3,287 6 (0.2)
  • HUS 202 35 (17.3)
  • 1O157H7

25
Enteric Fever
  • Bacterial pathogens ingested (facultative
    intracellular parasites)
  • Pathogens penetrate small intestinal mucosa,
    infect and multiply in intestinal lymphatic
    tissue (7-14 days), then disseminate by the
    lymphatic and hematogenous routes
  • Infection of the mononuclear phagocyte system
    (reticuloendothelial system), including lymph
    nodes, spleen, liver and bone marrow
  • Bacteremia secondary to infection of the
    mononuclear phagocyte system

26
Causes of Enteric Fever
  • Prototype Salmonella serotype Typhi (typhoid
    fever)
  • Other salmonellae S. serotype Paratyphi A, S.
    serotype Schottmuelleri (formerly Paratyphi B),
    S. serotype Hirschfeldii (formerly Paratyphi C)
    (paratyphoid fever) S. serotype Cholerasuis
  • Non-salmonellae Yersinia enterocolitica, Y.
    pseudotuberculosis, and Campylobacter fetus

27
Typhoid and Paratyphoid Fever
  • Ingestion of infectious inoculum (fecal
    contaminated food or water) followed within 5 to
    21 days by remittent fever that becomes sustained
    (occasional enterocolitis with fever for 3-4 days
    that resolves before fever)
  • Patients acutely ill with fever, chills,
    diaphoresis, dull frontal headache, anorexia,
    weakness, muscle pains
  • Leukopenia
  • Bradycardia (lt50)
  • Cutaneous rose spots (blanching erythematous
    maculopapular lesions) (30 typhoid fever, 3
    paratyphoid fever)

28
Typhoid Fever
  • Typhoid fever in the United States associated
    with international travel
  • During the period 1985-1994, of 2,445 reported
    typhoid cases, 72 associated with international
    travel, most frequently to Mexico, India, the
    Philippines, and Pakistan in descending order

29
Enteric Fever-Like Syndromes Due to
Non-Salmonellae
  • Fever and headache as in typhoid and paratyphoid
    fever
  • Fever with Yersinia intermittent not sustained as
    in Salmonella
  • Leukopenia infrequent
  • Acute diarrhea prominent feature of Yersinia
    enterocolitica
  • Salmonella enteric fever in individuals lt30 years
    of age, non-Salmonella gt40 years
  • Salmonella enteric fever associated with travel
    to developing countries, Yersinia to Northern
    Europe or no travel (acquisition in the United
    States), Campylobacter fetus not associated with
    foreign travel
  • Enteric fever with Yersinia and Campylobacter
    fetus associated with underlying disease
    especially cirrhosis
  • Campylobacter fetus has propensity for infection
    of vascular sites and is associated with
    thrombophlebitis

30
Complications of Typhoid Fever
  • Intestinal perforation third-fourth week of
    infection in untreated patients, due to
    hyperplasia, ulceration, and necrosis of
    ileocecal lymphoid tissue (3-10)
  • Aerobic and anaerobic bacteremia secondary to
    intestinal perforation
  • Localized infections endocarditis, pericarditis,
    pneumonia, orchitis, ovarian abscess formation

31
Mesenteric Adenitis
  • Variant of enteric fever with prominence of
    mesenteric lymph node infection (mesenteric
    lymphadenitis)
  • Fever and right lower quadrant pain mimicking
    acute appendicitis accompanied by diarrhea
  • Most common cause Yersinia enterocolitica and Y.
    pseudotuberculosis
  • More prevalent in Europe (especially Belgium)
    than the United States
  • Self-limited in vast majority of cases
  • Iatrogenic complication inappropriate surgery
    for acute appendicitis (avoid by helical
    appendiceal CT scan)

32
Toxin-Producing Clostridium difficile
  • Obligate anaerobic gram-positive bacilli
  • Pathogenic Clostridium difficile produces two
    exotoxins toxin A (enterotoxin) (MW308-kd) and
    toxin B (cytotoxin) (MW269-kd)
  • Toxin A and toxin B inactivate Rho proteins
    (GTP-binding proteins that regulate the actin
    cytoskeleton) in intestinal epithelial cells
    which results in apoptosis
  • Toxin A if infused in ligated loops of rabbit
    small intestine stimulates fluid accumulation
    with the efficiency of cholera toxin (toxin B
    lacks this activity)
  • Stains of C. difficile lacking toxin A
    demonstrate full potency in producing human
    colitis

33
Clostridium difficile Colitis
  • Disruption of colonic microbiota (Bacteroides,
    Prevotella predominant) by antibiotics
    (clindamycin, cephalosporins especially
    third-generation agents, ampicillin and
    amoxicillin, other penicillins, erythromycin and
    other macrolides, trimethoprim-sulfamethoxazole,
    tetracyclines) or antineoplastic drugs
    doxorubicin, cisplatin, cyclophosphamide,
    5-fluorouracil, chlorambucil, and methotrexate)
  • Colonization of colon by toxin-producing strain
    of Clostridium difficile (exogenous or endogenous
    source)
  • Colonic mucosal injury and inflammation
    (pseudomembranous colitis)

34
Clostridium difficile Colitis
  • Onset of diarrhea after 5 to 10 days of
    antibiotic treatment (nosocomial)
  • Diarrhea ranges from brief and self-limited to
    cholera-like with more than 20 stools per day
  • Fever (30 to 50)
  • Neutrophilic leukocytosis (50 to 60) (mean
    count of 15,000-16,000/mm3)
  • Abdominal pain or cramping (20 to 33)

35
Complications of Clostridium difficile Colitis
  • Toxic megacolon (mortality of 60)
  • Colonic perforation
  • Transverse volvulus
  • Protein-losing enteropathy
  • Recurrent C. difficile associated diarrhea (20)

36
Recurrent Clostridium difficile Colitis
  • Persistent disruption of colonic microbiota by
    metronidazole or vancomycin
  • Poor antibody response to toxin
  • Lack of antibiotic activity against bacterial
    spores

37
Laboratory Detection of Salmonella and Shigella
  • Sheep blood agar
  • MacConkey or eosin-methylene blue agar
  • Triple-sugar iron slant
  • Xylose-lysine-deoxycholate (XLD), Hektoen
    enteric, or Salmonella-Shigella agar
  • Enrichment broth (selenite or gram-negative)

38
Laboratory Detection of Yersinia
  • Same as for Salmonella and Shigella and in
    addition
  • Cold enrichment of stool specimens at
    refrigerator temperatures
  • Use of cefsulodin-irgasan-novobiocin (CIN) agar
    (Yersinia selective agar) Most enteric organisms
    inhibited (selective), and mannitol fermented by
    Yersinia which forms red bulls eye colonies (pH
    indicator neutral red) (differential)

39
NMH Short Series for Salmonella and Shigella
  • Cytochrome oxidase (OXI)
  • Lactose fermentation on MacConkey (MAC)
  • Motility (MOT)
  • Triple sugar iron agar (TSI)
  • Indole (IND)
  • Hydrogen sulfide (H2S)
  • Lysine-iron agar (LYI)
  • Urease (URE)
  • ONPG (ONP)

40
NMH Short Series for Clinically Important
Salmonella Serotypes1
  • OXI MAC MOT TSI IND H2S
    LYI URE ONP
  • Most nlf k/a2
  • Typhi nlf k/a3
    4
  • Para A nlf k/a2
  • 1R/O Salmonella indole, ONPT
  • 2Gas production
  • 3No gas production
  • 4Whisp of H2S below the slant

41
Series for Shigella and Other Enteric Pathogens1
  • OXI MAC MOT
    TSI IND H2S LYI URE ONP
  • Shigella k/a4
    /6 /7
  • Yersinia2 3
    a/a4 /
  • Vibrio
    a/a4
  • Aeromonas
    a/a5 /
  • Plesiomonas k/a4
  • 1R/O Shigella motility, a/a TSI, lysine,
    H2S, urea
  • R/O Yersinia lysine, H2S
  • 2Y. enterocolitica
  • 3At 37oC motile at 25oC
  • 4No gas production
  • 5Gas production
  • 6Serogroup A-C (25-500, serogroup D )
  • 7Serogroup A-C , serogroup D

42
Laboratory Detection of Enterohemorrhagic E. coli
  • Same as for Salmonella and Shigella and in
    addition
  • Sorbitol-containing MacConkey agar (SMAC) for
    detection of colorless sorbitol-negative colonies
    of Escherichia coli O157H7
  • Latex agglutination testing of colorless colonies
    (SMAC) for the somatic antigen O157
  • Direct immunoassay of stool specimens for Shiga
    toxin 1 and 2

43
Laboratory Detection of Campylobacter jejuni
  • Selective media containing antimicrobial agents
    to inhibit enteric bacterial flora
    (cefoperazone-containing media)
  • Microaerophilic ambient gas for incubation (5
    O2, 10 CO2, 85 N2)
  • Incubation temperature (42o C) for thermophilic
    growth

44
Laboratory Detection of Toxigenic Clostridium
difficile
  • Direct testing of stool specimens for presence of
    toxin A and toxin B (fibroblast cell-culture for
    cytotoxin, EIA for toxin A and B)
  • CCFA (cycloserine-cefoxitin-fructose agar) for
    detection for colonies with a yellow color
    (oxidative decarboxylation of peptones results in
    an alkaline pH, C. difficile non-fermentative for
    fructose, neutral red the pH indicator)
    (cycloserine inhibits gram-negatives especially
    E. coli, cefoxitin has broad activity against
    gram-negatives and gram-positives)
  • Testing of broth supernatant for presence of
    toxin A and B

45
Guidelines for Laboratory Evaluation of
Infectious Diarrhea
  • Community-acquired or travelers diarrhea
  • Nosocomial diarrhea (onset gt3 days after
    hospitalization)
  • Persistent diarrhea (gt7 days)
  • Immunocompromised patient (especially if HIV )
  • Thielman and Guerrant, Acute Infectious Diarrhea,
    New England Journal of Medicine,35038-47 (2004)

46
Community-acquired or travelers diarrhea
  • Culture for Salmonella, Shigella, and
    Campylobacter (if history of bloody diarrhea or
    hemolytic-uremic syndrome)
  • Culture for E. coli O157H7 and test for Shiga
    toxin (if recent antibiotics, chemotherapy, or
    hospitalization)
  • Culture and/or test for Clostridium difficile
    toxins A and B

47
Nosocomial diarrhea (onset gt3 days after
hospitalization)
  • Culture and/or test for C. difficile toxins A and
    B (if hospital outbreak of diarrhea or patient
    gt65 yr of age with coexisting conditions,
    immunocompromise, or neutropenia, or if systemic
    infection suscpeted) culture for Salmonella,
    Shigella, and Campylobacter (with blood cultures
    if systemic infection suspected) (if bloody
    diarrhea) culture for E. coli O157H7 and test
    for Shiga toxins

48
Persistent diarrhea (gt7 days)
  • Consider protozoa
  • Giardia
  • Cryptosporidium
  • Cyclospora
  • Isospora bell

49
Immunocompromised patient (especially if HIV )
  • Add
  • Microsporidium
  • Mycobacterium avium complex
  • Cytomegalovirus

50
Recommended Reading
  • Mandell, G.L., Bennett, J.E., and Dolin, R.
  • (Eds.). Mandell, Douglas, and Bennetts
  • Principles and Practice of Infectious
  • Diseases, Sixth Edition, Elsevier Churchill
  • Livingstone, 2005
  • Guerrant, R.L., and Steiner, T.S. Chapter 89.
    Gastrointestinal Infections and Food Poisoning.
  • Thielman, N.M., and Wilson, K.H. Chapter 92.
    Antibiotic-Associated Colitis.
  • Guerrant, R.L., and Lima, A. A. M. Chapter 93.
    Inflammatory Enteritides.
  • Thielman, N.M., and Guerrant, R.L. Chapter 94.
    Enteric Fever and Other Causes of Abdominal
    Symptoms With Fever.
Write a Comment
User Comments (0)
About PowerShow.com